NO984083L - Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmÕte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner - Google Patents

Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmÕte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner

Info

Publication number
NO984083L
NO984083L NO984083A NO984083A NO984083L NO 984083 L NO984083 L NO 984083L NO 984083 A NO984083 A NO 984083A NO 984083 A NO984083 A NO 984083A NO 984083 L NO984083 L NO 984083L
Authority
NO
Norway
Prior art keywords
aryl
preparation
hydroxyalkylpiperidines
cyanoheptane
glutarimides
Prior art date
Application number
NO984083A
Other languages
English (en)
Other versions
NO984083D0 (no
NO314498B1 (no
Inventor
Philippe Camus
Marcel Descamps
Joul Radisson
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984083(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO984083L publication Critical patent/NO984083L/no
Publication of NO984083D0 publication Critical patent/NO984083D0/no
Publication of NO314498B1 publication Critical patent/NO314498B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19984083A 1996-03-07 1998-09-04 Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmåte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner NO314498B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602880A FR2745811B1 (fr) 1996-03-07 1996-03-07 Glutarimide disubstitue procede pour sa preparation, et son utilisation
PCT/FR1997/000388 WO1997032852A1 (fr) 1996-03-07 1997-03-05 Glutarimides 3-aryl-3-carboxyalkyl substitues, leur preparation par cyclisation d'acides dicarboxyliques de la 4-aryl-4-cyanoheptane et leur utilisation pour la preparation de 3-aryl-3-hydroxyalkylpiperidines

Publications (3)

Publication Number Publication Date
NO984083L true NO984083L (no) 1998-09-04
NO984083D0 NO984083D0 (no) 1998-09-04
NO314498B1 NO314498B1 (no) 2003-03-31

Family

ID=9489959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984083A NO314498B1 (no) 1996-03-07 1998-09-04 Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmåte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner

Country Status (19)

Country Link
US (2) US6008360A (no)
EP (1) EP0888304B1 (no)
JP (1) JP3116051B2 (no)
AR (1) AR006139A1 (no)
AT (1) ATE206399T1 (no)
AU (1) AU2163497A (no)
BR (1) BR9707943C8 (no)
CA (1) CA2244771C (no)
CY (1) CY2276B1 (no)
DE (1) DE69707114T2 (no)
DK (1) DK0888304T3 (no)
ES (1) ES2165594T3 (no)
FR (1) FR2745811B1 (no)
MY (1) MY128754A (no)
NO (1) NO314498B1 (no)
PT (1) PT888304E (no)
TW (1) TW381080B (no)
WO (1) WO1997032852A1 (no)
ZA (1) ZA971999B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787449B3 (fr) * 1998-12-15 2001-01-12 Sanofi Sa Derives de 3-phenyl-2,6-dioxopiperidin-3-yl propionamide et leur procede de preparation
FR2787448B3 (fr) 1998-12-18 2001-01-12 Sanofi Sa Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation
DE10002509A1 (de) 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
WO2002046156A2 (en) 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379731A (en) * 1967-06-15 1968-04-23 Ciba Geigy Corp 1, 4-dihydro-1, 4-ethano-isoquinolines
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
BE787767A (fr) * 1971-08-21 1973-02-19 Merck Patent Gmbh Procede de preparation d'amides d'acides oxocarboxyliques et d'acides oxocarboxyliques
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.

Also Published As

Publication number Publication date
DE69707114D1 (de) 2001-11-08
FR2745811B1 (fr) 1998-05-22
ES2165594T3 (es) 2002-03-16
NO984083D0 (no) 1998-09-04
AU2163497A (en) 1997-09-22
CA2244771A1 (en) 1997-09-12
NO314498B1 (no) 2003-03-31
DK0888304T3 (da) 2002-03-04
BR9707943A (pt) 1999-07-27
CA2244771C (en) 2004-07-13
DE69707114T2 (de) 2002-06-06
EP0888304B1 (fr) 2001-10-04
JP3116051B2 (ja) 2000-12-11
CY2276B1 (en) 2003-07-04
WO1997032852A1 (fr) 1997-09-12
US6242607B1 (en) 2001-06-05
US6008360A (en) 1999-12-28
TW381080B (en) 2000-02-01
PT888304E (pt) 2002-02-28
JPH11506124A (ja) 1999-06-02
ATE206399T1 (de) 2001-10-15
AR006139A1 (es) 1999-08-11
BR9707943B (pt) 2008-05-20
MY128754A (en) 2007-02-28
BR9707943C8 (pt) 2014-11-18
EP0888304A1 (fr) 1999-01-07
FR2745811A1 (fr) 1997-09-12
ZA971999B (en) 1997-09-09

Similar Documents

Publication Publication Date Title
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
NO304551B1 (no) FremgangsmÕte ved fremstilling av sildenafil
NO992375L (no) FremgangsmÕte for fremstilling av benzylethere
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO994943D0 (no) Fremgangsmåte ved fremstilling av pyrazolo[4,3-d]pyrimidin-7-oner og mellomproduktet for disse
NO973680D0 (no) Fremgangsmåte for fremstilling av ikke-vandige dispersjoner og deres anvendelse
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20000182L (no) Fremgangsmåte for fremstilling av alkoksyfuranonamin- derivater, forbindelser frembragt ved fremgangsmåten og anvendelse av disse forbindelser
NO984083D0 (no) Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmÕte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO20005104L (no) Fremgangsmåte ved fremstillingen av pyrazolo[4,3-d]pyrimidin- 7-on-3-pyridylsulfonylforbindelser og intermediater derav
NO960307D0 (no) Fremgangsmåte ved fremstilling av substituerte 4,6-diamino-5-cyanopyrimidiner
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO985824L (no) Forbedret fremgangsmÕte for fremstilling av kaliumklavulanat
DK0782982T3 (da) Fremgangsmåde til fremstilling af o-chlormethyl-phenylglyoxylsyrederivater
NO994749D0 (no) FremgangsmÕte ved fremstillingen av tetraazamakrocykler
NO20013219L (no) Fremgangsmåte for fremstilling av trinatrium-pentacyanoamino- ferrat (II)
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
DK1048667T3 (da) Fremgangsmåde til fremstilling af 8-cyclopentyl-6-ethyl-3-(substitueret)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacener og dertil egnede mellemprodukter